Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle (Q43759228)

26 November 2017

Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle (English)

1 reference

26 November 2017

0 references

1 reference

1 reference

Perreault M

1

1 reference

PubMed ID

11590438

26 November 2017

Marette A

series ordinal

2

1 reference

PubMed ID

11590438

26 November 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

26 November 2017

1 reference

26 November 2017

7

1 reference

26 November 2017

1138-1143

1 reference

26 November 2017

10

1 reference

https://scigraph.springernature.com/pub.10.1038/nm1001-1138

26 November 2017

0 references

cites work

The L-arginine-nitric oxide pathway

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1138

Inducible nitric oxide synthase: what difference does it make?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1138

Nitric oxide and inflammatory joint diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1138

Role of nitric oxide in obesity-induced beta cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1138

Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1138

Lipotoxic heart disease in obese rats: implications for human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1138

Insulin resistance and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1138

Hypertriglyceridemia, insulin resistance, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1138

Cellular mechanisms of insulin resistance in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1138

Is type II diabetes mellitus a disease of the innate immune system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1138

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1138

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1138

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1138

Tumor necrosis factor alpha: a key component of the obesity-diabetes link

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1138

Tumor necrosis factor alpha inhibits signaling from the insulin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1138

IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1138

Tumor necrosis factor-alpha-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1138

Cytokines modulate glucose transport in skeletal muscle by inducing the expression of inducible nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1138

Expression of nitric oxide synthase in skeletal muscle: a novel role for nitric oxide as a modulator of insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1138

Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1138

Enhanced insulin-stimulated activation of phosphatidylinositol 3-kinase in the liver of high-fat-fed rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1138

Nitric oxide production by adipocytes: a role in the pathogenesis of insulin resistance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1138

Cytokines induce apoptosis in beta-cells isolated from mice lacking the inducible isoform of nitric oxide synthase (iNOS-/-).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1138

Hyperinsulinemia as an independent risk factor for ischemic heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1138

A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1138

1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1138

Allosteric inhibitors of inducible nitric oxide synthase dimerization discovered via combinatorial chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1138

Thiazolidinediones in the treatment of insulin resistance and type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1138

Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1138

Anti-inflammatory actions of 15-deoxy-delta 12,14-prostaglandin J2 and troglitazone: evidence for heat shock-dependent and -independent inhibition of cytokine-induced inducible nitric oxide synthase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1138

Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1138

Defective insulin-induced GLUT4 translocation in skeletal muscle of high fat-fed rats is associated with alterations in both Akt/protein kinase B and atypical protein kinase C (zeta/lambda) activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1138

Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1138

High-Fat Feeding Impairs Insulin-Stimulated GLUT4 Recruitment via an Early Insulin-Signaling Defect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1138

Physiological and toxicological actions of nitric oxide in the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1138

7 January 2021

The role of nitric oxide in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1138

7 January 2021

Effect of chronic treatment with the inducible nitric oxide synthase inhibitor N-iminoethyl-L-lysine or with L-arginine on progression of coronary and aortic atherosclerosis in hypercholesterolemic rabbits

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1138

7 January 2021

Inducible nitric oxide synthase colocalizes with signs of lipid oxidation/peroxidation in human atherosclerotic plaques

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1138

7 January 2021

Tumor necrosis factor alpha-induced pancreatic beta-cell insulin resistance is mediated by nitric oxide and prevented by 15-deoxy-Delta12,14-prostaglandin J2 and aminoguanidine. A role for peroxisome proliferator-activated receptor gamma activation

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1138

7 January 2021

Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1138

7 January 2021

Mechanism of impaired nitric oxide synthase activity in skeletal muscle of streptozotocin-induced diabetic rats

1 reference

https://api.crossref.org/works/10.1038%2FNM1001-1138

7 January 2021

Identifiers

DOI

10.1038/NM1001-1138

1 reference

26 November 2017

1 reference

PubMed ID

11590438